T-cell engager

T-cell engager

featured image of Candid and WuXi: $925 Million Cancer Breakthrough!
Companies

Candid and WuXi: $925 Million Cancer Breakthrough!

BIOT

Candid Therapeutics partners with WuXi Biologics to advance trispecific T-cell engagers, aiming for $925 million in potential milestones! 💰🌍📰

Bioprocessupdates

©2023 - 2026 BioprocessUpdates

PRIVACY POLICY terms of service contact